Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6037)
All Articles published online
|
Publishing Process of This Article
|
Sep 27, 2018 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dong TS, Aby ES, Benhammou JN, Kawamoto J, Han SH, May FP, Pisegna JR. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World J Hepatol 2018; 10(9): 612-621 [PMID: 30310539 DOI: 10.4254/wjh.v10.i9.612] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i9/612.htm |
| Number | Citing Articles |
| 1 |
Jihane N. Benhammou, Andrew M. Moon, Joseph R. Pisegna, Feng Su, Philip Vutien, Cynthia A. Moylan, George N. Ioannou. Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. Digestive Diseases and Sciences 2021; 66(7): 2394 doi: 10.1007/s10620-020-06457-2
|
| 2 |
Tiffany Khoo, Danielle Lam, John K Olynyk. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease. World Journal of Gastroenterology 2021; 27(29): 4831-4845 doi: 10.3748/wjg.v27.i29.4831
|
| 3 |
Jyh‐Jou Chen, Pei‐Lun Lee, Hung‐Chih Chiu, Hung‐Da Tung, Yen‐Cheng Chiu, Pin‐Nan Cheng. Real‐world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan. Journal of Gastroenterology and Hepatology 2020; 35(3): 467 doi: 10.1111/jgh.14845
|
| 4 |
Man Yuan, Juan Zhou, Lingyao Du, Libo Yan, Hong Tang. Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58786-x
|
| 5 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals. JGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
|
| 6 |
Tangui Barré, Marc Bourlière, Clémence Ramier, Fabrice Carrat, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Carole Cagnot, Céline Dorival, Fabien Zoulim, Jessica Zucman-Rossi, Jean-Charles Duclos-Vallée, Hélène Fontaine, Patrizia Carrieri. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort). Journal of Clinical Medicine 2022; 11(20): 6135 doi: 10.3390/jcm11206135
|
| 7 |
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Nefrología 2020; 40(1): 46 doi: 10.1016/j.nefro.2019.03.013
|
| 8 |
Jizheng Chen, Pan Qiu, Tingfeng Zhao, Haowei Jiang, Kebinur Tursun, Sulaiman Ksimu, Xinwen Chen, Qian Wang. Measures of insulin resistance and beta cell function before and after treatment of HCV infection. Virologica Sinica 2024; 39(4): 667 doi: 10.1016/j.virs.2024.06.007
|
| 9 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
| 10 |
Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, Kento Imajo, Takaomi Kessoku, Takumi Kawaguchi, Tatsuya Ide, Miwa Kawanaka, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Yoshihiro Kamada, Yoshio Sumida, Keizo Anzai, Masahito Shimizu, Takuji Torimura, Atsushi Nakajima, Katsutoshi Tokushige, Kazuaki Chayama, Yuichiro Eguchi. Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study. JGH Open 2021; 5(2): 228 doi: 10.1002/jgh3.12474
|
| 11 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 12 |
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Nefrología (English Edition) 2020; 40(1): 46 doi: 10.1016/j.nefroe.2019.03.014
|
| 13 |
Lohanna STRAUHS-NITSCH, Marcela Ferro CAMPIOLO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Claudia Alexandre Pontes IVANTES. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR. Arquivos de Gastroenterologia 2020; 57(3): 267 doi: 10.1590/s0004-2803.202000000-50
|